Obesity drug sales soar

Obesity drug sales soar
6 feb 2024 · 4 min. 42 sec.

Eli Lilly https://seekingalpha.com/news/4063037-eli-lilly-stock-gains-q4-beats-obesity-drugs?source=wsb_podcast:obesity_drug_sales_soar sales forecasts. (0:16) DuPont https://seekingalpha.com/news/4063007-duponts-stock-rises-on-dividend-hike-stock-buyback?source=wsb_podcast:obesity_drug_sales_soar and launches buyback. (1:37) NYCB's https://seekingalpha.com/news/4062935-nycbs-drastic-financial-moves-followed-tense-talks-with-occ-report?source=wsb_podcast:obesity_drug_sales_soar left before it announced shock results. (2:38) Show Notes https://seekingalpha.com/news/4062707-oppenheimers-buy-vs-sell-ideas-paired-by-each-smid-sector?source=wsb_podcast:obesity_drug_sales_soar https://seekingalpha.com/news/4063082-docusign-to-shrink-headcount-company-will-stay-public-after-failed-takeover-talks?source=wsb_podcast:obesity_drug_sales_soar Episode transcripts https://seekingalpha.com/wsb?source=wsb_podcast:obesity_drug_sales_soar Sign up...

mostra di più
Eli Lilly easily beats sales forecasts. (0:16) DuPont boosts its dividend and launches buyback. (1:37) NYCB's head of risk left before it announced shock results. (2:38)

Show Notes
Oppenheimer's Buy vs. Sell ideas paired by each SMID sector
DocuSign to shrink headcount; company will stay public after failed takeover talks

Episode transcripts seekingalpha.com/wsb

Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
mostra meno
Autore Seeking Alpha
Sito seekingalpha.com

Sembra che non tu non abbia alcun episodio attivo

Sfoglia il catalogo di Spreaker per scoprire nuovi contenuti


Copertina del podcast

Sembra che non ci sia nessun episodio nella tua coda

Sfoglia il catalogo di Spreaker per scoprire nuovi contenuti


Copertina dell'episodio Copertina dell'episodio

Che silenzio che c’è...

È tempo di scoprire nuovi episodi!

La tua Libreria